Intuitive Surgical (NASDAQ:ISRG) reported a solid second quarter of 2026, with management pointing to continued global ...

Intuitive Surgical, Boston Scientific and Stryker remain in focus as demand, execution and capital discipline shape the US ...

ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for investors seeking stronger long-term MedTech growth.

J&J Ottava robotic surgery won FDA de novo authorization for ten general surgery procedures on July 22, 2026, breaking ...

It's worth noting that the stock has a recent history of earnings beats, bettering analysts' predictions in each of the past four quarters. If Intuitive reports better earnings than the current ...

Intuitive Surgical (NASDAQ:ISRG) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call ...

Slowing Procedure Growth and Tariffs Take Center Stage Just now Live Intuitive Surgical’s (NASDAQ: ISRG) second-quarter ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Qualcomm, Intuitive Surgical and Stryker lead today's top analyst reports, spotlighting growth drivers, strategic initiatives and ongoing challenges.

Chip stocks led a global sell-off, Netflix plunged on weak guidance, and U.S.-Iran tensions weighed on investor sentiment.

Surgerii Robotics announced today that it completed the first European installation of its Shurui single-port (SP) surgical ...

Wall Street slipped as a deepening chip selloff weighed on sentiment, with the Nasdaq leading losses. Nvidia declined while ...